In English | En español
¿Preguntas sobre el cáncer? 1-800-422-6237

Linfoma de Hodgkin infantil: Tratamiento (PDQ®)

  • Actualización: 28 de agosto de 2014

Cuadro 8. Linfoma de Hodgkin, predominio linfocítico, nodular

Quimioterapia (No. de cursos)a Radiación (Gy) Número de pacientes Supervivencia sin complicaciones (número de años de seguimiento) Supervivencia (número de años de seguimiento) 
COPP/ABV (4)b [23]Ninguno5296% (5)100% (5)
IFRT (21)29100% (5)
CVP (3) [46]Ninguno5574% (5)100% (5)
VAMP (4)c [50]Ninguno2687,5% (5)N/A
IFRT (25)6
VAMP (4) [42]IFRT (15–25,5)33100% (10)100% (10)
Ningunod [21]Ninguno5167% (2)100% (2)
DBVE (2–4)c [44]Ninguno2694% (8)100% (8)
IFRT (25.5)

IFRT = radioterapia con compromiso de campo; N/A = no corresponde; No. = número.
aPara mayor información sobre los regímenes quimioterapéuticos, consultar el Cuadro 4.
bAsignación o no a radioterapia con base en la respuesta al tratamiento.
cAsignación con base en la respuesta clínica.
dExtirpación de todos los ganglios linfáticos comprometidos.

Bibliografía

  1. Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, et al.: Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110 (1): 179-85, 2007.  [PUBMED Abstract]

  2. Appel BE, Chen L, Buxton A, et al.: Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group. Pediatr Blood Cancer 59 (7): 1284-9, 2012.  [PUBMED Abstract]

  3. Donaldson SS, Link MP, Weinstein HJ, et al.: Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 25 (3): 332-7, 2007.  [PUBMED Abstract]

  4. Tebbi CK, Mendenhall NP, London WB, et al.: Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group. Pediatr Blood Cancer 59 (7): 1259-65, 2012.  [PUBMED Abstract]

  5. Shankar A, Hall GW, Gorde-Grosjean S, et al.: Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report. Eur J Cancer 48 (11): 1700-6, 2012.  [PUBMED Abstract]

  6. Metzger ML, Weinstein HJ, Hudson MM, et al.: Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 307 (24): 2609-16, 2012.  [PUBMED Abstract]